📰 Sam Eiber News
Page 5 - Sam Eiber News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sam Eiber. Real-time updates on events, politics, business and more.
February 9, 2023
New Brighton-based Cardiovascular Systems is slated to bring new, complementary products to Abbott's existing offerings.
December 16, 2022
BTIG analysts maintained their neutral rating for Embecta (Nasdaq:EMBC) ahead of the company's fourth-quarter earnings report next week.
December 14, 2022
Masimo is rolling out a software upgrade that will enable millions of high-end home entertainment systems to become health information hubs.
November 9, 2022
Masimo reported third-quarter results that beat the consensus forecast on Wall Street — but it held down its Q4 guidance.
September 8, 2022
Embecta (Nasdaq:EMBC), the BD diabetes business spinoff, may take a few years to move into a growth phase, analysts say.
August 3, 2022
VRAY earnings call for the period ending June 30, 2022.
July 26, 2022
Prescription digital therapeutics company Pear Therapeutics is letting go of roughly 25 employees, representing 9% of its workforce.
May 8, 2022
Vapotherm, Inc. (NYSE:NYSE:VAPO) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Mark Klausner - Westwicke Partners Joseph Army - CEO, President & Director...
May 8, 2022
ViewRay, Inc. (NASDAQ:NASDAQ:VRAY) Q1 2022 Earnings Conference Call May 5, 2022, 4:30 PM ET Company Participants Matt Harrison - Director, Investor Relations Scott Drake - President and CEO...
May 6, 2022
VRAY earnings call for the period ending March 31, 2022.